All Stories

  1. Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin

    Article • OncoTargets and Therapy, April 2017, Dove Medical Press

    Mrs Jialan Zang

  2. Serum levels of VEGF can serve as a predictive biomarker in non-small cell long cancer

    Article • OncoTargets and Therapy, January 2017, Dove Medical Press

    Mrs Jialan Zang